1. Home
  2. DELL vs PFE Comparison

DELL vs PFE Comparison

Compare DELL & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DELL

Dell Technologies Inc.

HOLD

Current Price

$209.02

Market Cap

140.5B

Sector

Technology

ML Signal

HOLD

Logo Pfizer Inc.

PFE

Pfizer Inc.

HOLD

Current Price

$26.41

Market Cap

155.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DELL
PFE
Founded
1984
1849
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.5B
155.2B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
DELL
PFE
Price
$209.02
$26.41
Analyst Decision
Buy
Buy
Analyst Count
17
14
Target Price
$181.63
$29.29
AVG Volume (30 Days)
5.2M
25.3M
Earning Date
05-28-2026
05-05-2026
Dividend Yield
1.23%
6.55%
EPS Growth
36.05
N/A
EPS
8.68
1.36
Revenue
$113,538,000,000.00
$62,579,000,000.00
Revenue This Year
$26.19
N/A
Revenue Next Year
$8.60
N/A
P/E Ratio
$23.97
$19.61
Revenue Growth
18.80
N/A
52 Week Low
$92.53
$21.97
52 Week High
$221.50
$28.75

Technical Indicators

Market Signals
Indicator
DELL
PFE
Relative Strength Index (RSI) 64.52 42.84
Support Level $116.09 $24.99
Resistance Level N/A $26.65
Average True Range (ATR) 8.31 0.51
MACD -0.74 -0.10
Stochastic Oscillator 71.96 12.46

Price Performance

Historical Comparison
DELL
PFE

About DELL Dell Technologies Inc.

Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Share on Social Networks: